BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20670621)

  • 1. Some cardiovascular therapeutics inhibit paraoxonase 1 (PON1) from human serum.
    Işgör MM; Beydemir S
    Eur J Pharmacol; 2010 Oct; 645(1-3):135-42. PubMed ID: 20670621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the impacts of antibiotic drugs on PON 1; a major bioscavenger against cardiovascular diseases.
    Ekinci D; Beydemir S
    Eur J Pharmacol; 2009 Sep; 617(1-3):84-9. PubMed ID: 19577563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel purification strategy for human PON1 and inhibition of the activity by cephalosporin and aminoglikozide derived antibiotics.
    Sinan S; Kockar F; Arslan O
    Biochimie; 2006 May; 88(5):565-74. PubMed ID: 16600468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibition effect of some dihydroxy coumarin compounds on purified human serum paraoxonase 1 (PON1).
    Erzengin M; Basaran I; Cakir U; Aybey A; Sinan S
    Appl Biochem Biotechnol; 2012 Nov; 168(6):1540-8. PubMed ID: 22971832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential hydrolysis of homocysteine thiolactone by purified human serum (192)Q and (192)R PON1 isoenzymes.
    Bayrak A; Bayrak T; Demirpençe E; Kılınç K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(1):49-55. PubMed ID: 21123122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of PON1 from human serum and assessment of enzyme kinetics against metal toxicity.
    Ekinci D; Beydemir S
    Biol Trace Elem Res; 2010 Jun; 135(1-3):112-20. PubMed ID: 19727574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotics Used in Patients after Surgery and Effects of Human Serum Paraoxonase-I (PON1) Enzyme Activity.
    Yılmaz A; Dilek E
    Protein Pept Lett; 2019; 26(3):215-220. PubMed ID: 30678610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of human serum paraoxonase-1 with some respiratory drugs.
    Gökçe B; Sarıoğlu N; Gençer N; Arslan O
    J Biochem Mol Toxicol; 2019 Dec; 33(12):e22407. PubMed ID: 31581362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An alternative purification method for human serum paraoxonase 1 and its interaction with methidathion.
    Gençer N; Yavuz E
    Arch Physiol Biochem; 2017 Jul; 123(3):159-164. PubMed ID: 28276711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant and antipsychotic drugs differentially affect PON1 enzyme activity.
    Avcikurt AS; Sinan S; Kockar F
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):245-9. PubMed ID: 24934243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification human PON1Q192 and PON1R192 isoenzymes by hydrophobic interaction chromatography and investigation of the inhibition by metals.
    Gençer N; Arslan O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(3):134-40. PubMed ID: 19084484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous anesthetics inhibit human paraoxonase-1 (PON1) activity in vitro and in vivo.
    Alici HA; Ekinci D; Beydemir S
    Clin Biochem; 2008 Nov; 41(16-17):1384-90. PubMed ID: 18640108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of Holstein bull semen paraoxonase 1 (PON1) by hydrophobic interaction chromatography and investigation of its inhibition kinetics by heavy metals.
    Dedeoğlu N; Arslan M; Erzengin M
    Biol Trace Elem Res; 2014 Apr; 158(1):29-35. PubMed ID: 24563030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects of thirty-eight cardiac drugs on human serum paraoxonase.
    Argan O; Cikrikci K; Uslu H; Gencer N
    Chem Biol Drug Des; 2022 Jul; 100(1):80-89. PubMed ID: 35395139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of Potential Paraoxonase-I Inhibitors by Kinetic and Molecular Docking Studies: Chemotherapeutic Drugs.
    Türkeş C
    Protein Pept Lett; 2019; 26(6):392-402. PubMed ID: 30819074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple procedures for purification and stabilization of human serum paraoxonase-1.
    Golmanesh L; Mehrani H; Tabei M
    J Biochem Biophys Methods; 2008 Apr; 70(6):1037-42. PubMed ID: 17928061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro inhibition effect of some coumarin compounds on purified human serum paraoxonase 1 (PON1).
    Gokce B; Gencer N; Arslan O; Karatas MO; Alici B
    J Enzyme Inhib Med Chem; 2016 Aug; 31(4):534-7. PubMed ID: 25982292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impacts of some antibiotics on human serum paraoxonase 1 activity.
    Dilek EB; Küfrevioğlu Öİ; Beydemir Ş
    J Enzyme Inhib Med Chem; 2013 Aug; 28(4):758-64. PubMed ID: 22591317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
    Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
    J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of some drugs on human erythrocyte 6-phosphogluconate dehydrogenase: an in vitro study.
    Akkemik E; Budak H; Ciftci M
    J Enzyme Inhib Med Chem; 2010 Aug; 25(4):476-9. PubMed ID: 20235752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.